In Vivo Modulation of Vaccine-Induced Immune Responses toward a Th1 Phenotype Increases Potency and Vaccine Effectiveness in a Herpes Simplex Virus Type 2 Mouse Model

Por Sin, Jeong-Im, Kim, Jong J., Boyer, Jean D., Ciccarelli, Richard B., Higgins, Terry J., Weiner, David B.
Publicado em 1999

Phase I Study of a Herpes Simplex Virus Type 2 (HSV-2) DNA Vaccine Administered to Healthy, HSV-2-Seronegative Adults by a Needle-Free Injection System

Por Cattamanchi, Ashok, Posavad, Christine M., Wald, Anna, Baine, Yaela, Moses, Jennifer, Higgins, Terry J., Ginsberg, Richard, Ciccarelli, Richard, Corey, Lawrence, Koelle, David M.
Publicado em 2008

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)

Por Fuchs, Jonathan D., Frank, Ian, Elizaga, Marnie L., Allen, Mary, Frahm, Nicole, Kochar, Nidhi, Li, Sue, Edupuganti, Srilatha, Kalams, Spyros A., Tomaras, Georgia D., Sheets, Rebecca, Pensiero, Michael, Tremblay, Marc A., Higgins, Terry J., Latham, Theresa, Egan, Michael A., Clarke, David K., Eldridge, John H.
Publicado no Open Forum Infect Dis (2015)